1. I. Martins (2014). The Global Obesity Epidemic is Related to Stroke, Dementia and Alzheimer’s disease. JSM Alzheimer’s Dis Related Dementia, 1(2), 1010.
2. Dirk Sander,Kerstin Sander,Holger Poppert (2008). Review: Stroke in type 2 diabetes. The British Journal of Diabetes & Vascular Disease, 8(5), 222-229.
3. Ian Martins,Wei Lim,Andrea Wilson,Simon Laws,Ralph Martins (2013). The acceleration of aging and Alzheimer’s disease through the biological mechanisms behind obesity and type II diabetes. Health, 5(05), 913-920.
4. I. Martins (2013). Increased Risk for Obesity and Diabetes with Neurodegeneration in Developing Countries. Journal of Molecular and Genetic Medicine, s1(01), 1.
5. Martins I.J,Wilson A.C,Lim W.L.F,Laws S.M,et Laws S.M (2012). Sirtuin 1 mediates the obesity induced risk of common degenerative diseases: Alzheimer’s disease, coronary artery disease and type 2 diabetes. Health, 4(12), 1448-1456.
6. Monte De la,J. Wands (2008). Alzheimer’s disease is Type 3 diabetes- Evidence Reviewed. Journal of Diabetes and Science Technology, 2(5), 1101-1113.
7. I. Martins (2014). Nutritional and Genotoxic Stress Contributes to Diabetes and Neurodegenerative Diseases such as Parkinson's and Alzheimer's Diseases. Frontiers in Clinical Drug Research - CNS and Neurological Disorders, 3
8. Yoshino J,Klein S (2013). A Novel Link Between Circadian Clocks and Adipose Tissue Energy Metabolism. Diabetes, 62(7), 2175-2177.
9. Creegan Martins IJ,Lim W.L.F,Martins R.N (2013). Molecular insights into appetite control and neuroendocrine disease as risk factors for chronic diseases in Western countries. Special Issue. Molecular Mechanisms Involved in Inflammation and Insulin Resistance in Chronic Diseases and Possible Interventions. Open J Endocr Metab Dis, 3, 11-33.
10. Ian Martins,Rhona Creegan (2014). Links between Insulin Resistance, Lipoprotein Metabolism and Amyloidosis in Alzheimer’s Disease. Health, 06(12), 1549-1579.
11. Ian Martins (2014). Induction of NAFLD with Increased Risk of Obesity and Chronic Diseases in Developed Countries. Open Journal of Endocrine and Metabolic Diseases, 04(04), 90-110.
12. Dirk Sander,Kerstin Sander,Holger Poppert (2008). Review: Stroke in type 2 diabetes. The British Journal of Diabetes & Vascular Disease, 8(5), 222-229.
13. Laedtke Janson J,O'Brien Parisi J.E,Petersen R.C,Butler P.C (2004). Increased Risk of Type 2 Diabetes in Alzheimer Disease. Diabetes, 53(2), 474-481.
14. H. Liang,Y. Zhong,S. Zhou,Q. Li (2011). Palmitic acid-induced apoptosis in pancreatic β-cells is increased by liver X receptor agonist and attenuated by eicosapentaenoate. In Vivo, 25(5), 711-8.
15. Maedler K,Dyntar Spinas G.A,Kaiser Moritz W,et al (2001). Distinct Effects of Saturated and Monounsaturated Fatty Acids on β-Cell Turnover and Function. Diabetes, 50(1), 69-76.
16. Wang C,Guan Y,Yang J (2010). Cytokines in the Progression of Pancreatic β-Cell Dysfunction International Journal of Endocrinology;Volume. International Journal of Endocrinology, 2010, 1-10.
17. Louis Feurino,William Fisher,Uddalak Bharadwaj,Qizhi Yao,Changyi Chen,Min Li (2006). Current Update of Cytokines in Pancreatic Cancer: Pathogenic Mechanisms, Clinical Indication, and Therapeutic Values. Cancer Investigation, 24(7), 696-703.
18. Alonso-Magdalena Ropero A.B,Ripoll García-García E,et Fuentes E (2008). Bisphenol‐A disruption of the endocrine pancreas and blood glucose homeostasis. International Journal of Andrology, 31(2), 194-200.
19. Chi Yang J,Guan Burkhardt B.R,Wolf B.A (2010). Leucine metabolism in regulation of insulin secretion from pancreatic beta cells. Nutr Rev, 68(5), 270-279.
20. Brouwer A.E,Carroll P.B,Atwater I.J (1991). Effects of Leucine on Insulin Secretion and Beta Cell Membrane Potential in Mouse Islets of Langerhans. Pancreas, 6(2), 221-228.
21. Zawalich W.S,Zawalich K.C (1997). Influence of pyruvic acid methyl ester on rat pancreatic islets, Effects on insulin secretion, phosphoinositide hydrolysis, and sensitization of the beta cell.J. Biol. Chem, 272(6), 3527-3531.
22. Michael MacDonald (1995). Feasibility of a mitochondrial pyruvate malate shuttle in pancreatic islets. Further implication of cytosolic NADPH in insulin secretion. J Biol. Journal of Biological Chemistry, 271(9), 5287a.
23. Bakowski D,Parekh A.B (2007). Regulation of Store-Operated Calcium Channels by the Intermediary Metabolite Pyruvic Acid. Curr Biol, 17(12), 1076-1081.
24. Xiaocun Sun,Michael Zemel (2007). Leucine and Calcium Regulate Fat Metabolism and Energy Partitioning in Murine Adipocytes and Muscle Cells. Lipids, 42(4), 297-305.
25. Dunn K.M,Nelson M.T (2010). Calcium and diabetic vascular dysfunction. Focus on “Elevated Ca2+ sparklet activity during acute hyperglycemia and diabetes in cerebral arterial smooth muscle cells”. Focus on “Elevated Ca2+ sparklet activity during acute hyperglycemia and diabetes in cerebral arterial smooth muscle cells. Am J Physiol Cell Physiol; 298: C203–C205, C203-C205.
26. Parekh A.B (2000). Calcium signaling and acute pancreatitis: Specific response to a promiscuous messenger. Proc Natl Acad Sci U S A, 97(24), 2933-1293.
27. Katherine Whalley (2011). Circadian rhythm: Calcium sets the tempo. Nature Reviews Neuroscience, 12(8), 434-435.
28. I. Martins (2013). Appetite dysregulation and obesity in Western Countries. Ebook project
29. Carl Lavie,Mandeep Mehra,Richard Milani (2005). Obesity and heart failure prognosis: paradox or reverse epidemiology?. European Heart Journal, 26(1), 5-7.
30. B. Mathew (2008). Obesity: Effects on Cardiovascular Disease and its Diagnosis. The Journal of the American Board of Family Medicine, 21
31. L. Guarente (2007). Sirtuins in Aging and Disease. Cold Spring Harbour Symposium Quantitative Biology, 72
32. M. Hansen,T. Connolly (2008). Nuclear receptors as drug targets in obesity, dyslipidemia and atherosclerosis. Current Opinion Investigational Drugs, 9(3)
33. I. Martins (2015). Unhealthy Nutrigenomic Diets Accelerate NAFLD and Adiposity in Global communities.
34. Bullen JW,Bluher S,Kelesidis T,Mantzoros CS (2007). Regulation of adiponectin and its receptors in response to development of diet-induced obesity in mice. Am J Physiol Endocrinol Metab, 292
35. Al-Attas O.S,Al-Rubeaan Al-Daghri N.M,da N.F,et Sabico S.L (2009). Changes in endotoxin levels in T2DM subjects on anti-diabetic therapies. Cardiovascular Diabetology, 8(1), 20.
36. Vaccaro M.I,Calvo E.L,Suburo A.M,Lanosa Sordelli D.O,et al (2000). Lipopolysaccharide directly affects pancreatic acinar cells: implications on acute pancreatitis pathophysiology. Dig Dis Sci, 45(5), 915-926.
37. Ian Martins (2015). LPS Regulates Apolipoprotein E and Aβ Interactionswith Effects on Acute Phase Proteins and Amyloidosis. Advances in Aging Research, 04(02), 69-77.
38. I. Martins,V. Gupta,A. Wilson,S. Fuller,R. Martins (2014). Interactions Between Apo E and Amyloid Beta and their Relationship to Nutriproteomics and Neurodegeneration. Current Proteomics, 11(3), 171-183.
39. Carol Murray,Donal Skelly,Colm Cunningham (2011). Exacerbation of CNS inflammation and neurodegeneration by systemic LPS treatment is independent of circulating IL-1β and IL-6. Journal of Neuroinflammation, 8(1), 50.
40. Lee,Magkos Mantzoros,C. Kang,E. (2011). Effects of leptin and adiponectin on pancreatic β-cell function. Metabolism, 60(12), 1664-1672.
41. Wang L.,Li L.,Ran X.,Long M.,Zhang M. (2013). Lipopolysaccharides reduce adipogenesis in 3T3-L1 adipocytes through activation of NF-κB pathway and downregulation of AMPK expression. Cardiovasc Toxicol, 13(4), 338-46.
42. Kadiri Vatier C,Chapron Muscat A,et Capeau J (2012). Visceral and subcutaneous adipose tissue from lean women respond differently to lipopolysaccharide-induced alteration of inflammation and glyceroneogenesis Nutrition and Diabetes. Nutrition & Diabetes, 2(12), e51-e51.
43. Feng Wang,Margery Herrington,Jörgen Larsson,Johan Permert (2003). The relationship between diabetes and pancreatic cancer. Molecular Cancer, 2(1), 4.
44. Morrison M (2012). Pancreatic Cancer and Diabetes. Adv Exp Med Biol, 771, 229-239.
45. Machann Heni M,Staiger H,Peter Schwenzer N.F,et al (2010). Pancreatic fat is negatively associated with insulin secretion in individuals with impaired fasting glucose and/or impaired glucose tolerance: a nuclear magnetic resonance study.
46. S. Collins,C. Londos,D. Gauguier,A. Clark (2008). Pancreatic ectopic fat is characterized by adipocyte infiltration and altered lipid composition. Obesity (Silver Spring, 26(3), 522.
47. Shi-Ping Ding,J. Li,Jin (2003). A mouse model of severe acute pancreatitis induced with caerulein and lipopolysaccharide. World J, 9(3), 584.
48. Nakamura Shimizu K,Ayabe K,T,T. Taira (2015). Bacterial cell wall components regulate adipokine secretion from visceral adipocytes. J. Clinical Biochem Nutr, 9(3), 584-589.
49. S. Obara,Ariyoshi Akifusa S,Usui Okinaga T (2014). Pyroglutamated Apelin-13 Inhibits Lipopolysaccharide-Induced Production of Pro-Inflammatory Cytokines in Murine Macrophage J774.1 Cells. Modern Research in Inflammation, 03(02), 59-66.
50. Hashimoto Kubota N,et Eto K (2008). Adiponectin induces insulin secretion in vitro and in vivo at a low glucose concentration. Diabetologia, 51(5), 59-66.
